Arbutus Biopharma Corporation ABUS Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's interest coverage?
- Arbutus Biopharma Corporation (ABUS) reported interest coverage of 1,819.2× in Q1 2026.
- How has Arbutus Biopharma Corporation's interest coverage changed year-over-year?
- Arbutus Biopharma Corporation's interest coverage increased by 366.3% year-over-year, from -683.1× to 1,819.2×.
- What is the long-term trend for Arbutus Biopharma Corporation's interest coverage?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's interest coverage has grown at a 93.7% compound annual growth rate (CAGR), from -14.4× to -393.4×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.